Tom Brady Takes Lead Role at eMed as GLP-1 Market Surges to $150B
NFL star Tom Brady has become eMed's chief wellness officer, targeting the rapidly expanding GLP-1 weight-loss industry valued at $150 billion. His role highlights increasing athlete engagement and clinical oversight in health innovation.
· 70d ago
